LSE:CNA - Centrica has spent 2026 reshaping its long-term profile, most visibly through nuclear power. Within a fortnight in July, the British Gas owner announced a regulated contract to keep Sizewell B running until 2055 and a further two-year extension for two older stations in which it holds a stake. The central question is why Centrica is leaning so heavily on nuclear, and what its latest half-year figures reveal about the wider group.
What Centrica Does
Centrica is a UK-based energy services and solutions company listed on the London Stock Exchange's Main Market under the code CNA. Its best-known Business is British Gas, which supplies households. In its 2026 interim results, the group reported Earnings across three broad areas: Retail, which covers customer-facing Supply and services; Optimisation, which includes energy trading and asset optimisation activity; and Infrastructure, which includes power generation, gas storage and its 20 per cent share of the UK nuclear fleet operated alongside EDF Energy.
The Nuclear Announcements
On 9 July 2026, Centrica said it had secured a 20-year regulated Contract for Difference for Sizewell B, the 1.2GW station in Suffolk, allowing operation to be extended from 2035 to 2055. According to that announcement, the Strike Price is £70.50/MWh in 2025 prices, indexed to CPI. Centrica stated that its share of the roughly £800 million life extension Investment is about £160 million, and that this is expected to be funded from operating cash flows within the existing nuclear Partnership over 15 years, with no additional Equity injection required. The release described "a clear, regulated framework through to the 2050s."
On 22 July 2026, the company announced that Heysham 1 and Hartlepool, in which it also holds 20 per cent stakes, would have their closure dates pushed back by two years to March 2030. Centrica said this would add approximately 6 TWh of incremental generation for its share and would not require material upfront capital. Heysham 2 and Torness remain scheduled to close in March 2030. The company also noted its 15 per cent stake in Sizewell C, with investment capped at £1.3 billion.
Half-Year Results in Context
On 23 July 2026, Centrica published its interim results for the six months to 30 June 2026. The group reported adjusted operating profit of £497 million, compared with £549 million a year earlier, and adjusted Earnings Per Share of 6.8p against 7.0p. Statutory Basic Earnings Per Share were 11.7p, compared with a loss of 5.1p in the first half of 2025. Adjusted net cash stood at £709 million, down from £1.5 billion at the end of 2025. The board declared an Interim Dividend of 2.0p per share, up from 1.83p, which was paid on 22 September 2026.
Chief executive Chris O'Shea said: "Our operational foundations are strong, commercial performance is improving, and we continue to progress our transformation programme as we drive efficiency through the organisation." Centrica reiterated its long-term ambitions of £2.0 billion adjusted EBITDA and doubling earnings per share by 2030 compared with 2025.
Risks and What to Watch
Lower adjusted profit and net cash show earnings remain sensitive to Commodity prices, weather and trading. Nuclear life extensions depend on continued safety and regulatory clearance, and ageing stations can face unplanned outages. The Sizewell C commitment is large and long-dated, bringing construction and cost-overrun risk. Retail supply remains exposed to price caps. Updates on nuclear output and progress towards the 2030 targets will be important markers.
Conclusion
Centrica's nuclear moves in July 2026 appear designed to add regulated, longer-duration earnings to a group whose first-half profit and cash position softened. The reported figures suggest the strategy is about stabilising returns over decades rather than lifting near-term results, with delivery against the 2030 targets the key test.






Please wait processing your request...